TRIO PHARMA ApS: Financial statements 2026
CVR: 36499281
Source: annual report 2026, Danish Business Authority
01/05/2025 – 30/04/2026
TRIO PHARMA ApS (CVR 36499281) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -6,630 and a net result of DKK -471,483 compared with DKK -1,170,880 the year before. Equity in the 2026 report amounted to DKK -3,065,016. The company had 1 employee in the financial year.
- Gross Profit
- DKK -6,630
- Profit/Loss
- DKK -471,483
- Equity
- DKK -3,065,016
- Total Assets
- DKK 1,408,800
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | -7K | -471K | -3.1M | 1 |
| 2025 | - | -412K | -1.2M | -2.6M | 2 |
| 2024 | - | -289K | -490K | -1.4M | 1 |
| 2023 | - | -491K | -889K | -933K | 2 |
| 2022 | - | -423K | 9M | -44K | 1 |
Official annual report
Find more companies like TRIO PHARMA ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout TRIO PHARMA ApS
TRIO PHARMA ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christian Bo Ratje. The board consists of Michael John Ratje (chair), Christian Bo Ratje and Kirstine Laura Ratje-Johansen. The company is owned by STINE RATJE HOLDING ApS and CHRISTIAN RATJE HOLDING ApS. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -6,630 and a net result of DKK -471,483 compared with DKK -1,170,880 the year before. Equity in the 2026 report amounted to DKK -3,065,016.